Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Transportation, E-Commerce & Mechanical Systems
6 pending office actions • 5 clients • 6 examiners • 4 art units • 0 of 6 (0%) have an AI response strategy ready
Sierra IP Law, PC focuses on the Biotechnology & Pharmaceuticals technology area, with 654 career applications. The firm has achieved a resolved allowance rate pct of 79.06. Currently, there are 3 pending office actions in its docket. The 654 career applications show a specialized focus within the biotechnology sector.
The average office actions per allowance for this profile is 2.61. This figure suggests the prosecution process for reaching an allowance in the Biotechnology & Pharmaceuticals field. The 79.06 resolved allowance rate pct reflects the firm's success rate for the 654 career applications it has managed. With only 3 pending office actions, the firm's current active workload is focused. These data points together illustrate the firm's historical performance and its current status within its primary technology area.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (17%) |
| §103 only | 1 (17%) |
| §112 only | 1 (17%) |
| Double-patenting + other | 1 (17%) |
| Multi-statute (no §101) | 2 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| REYES, REGINALD R | 1 | 41.0% | +31.9% |
| HARCOURT, BRAD | 1 | 84.2% | +5.3% |
| WAX, ROBERT A | 1 | 25.0% | +3.9% |
| NORRIS, CLAIRE A | 1 | 65.8% | +28.0% |
| LIU, SUE XU | 1 | 20.9% | +18.6% |
| DAVIS, RUTH A | 1 | 60.8% | +31.1% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18985084 | TREE FRUIT OR NUT HARVESTER TO MINIMIZE MACHINE PASSES IN THE ORCHARD | HARCOURT, BRAD | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18120319 | COMPOSITIONS INCLUDING ENDOPHYTES FOR IMPROVING PLANT NUTRITION, GROWTH,AND PERFORMANCE AND METHODS OF USING THE SAME | DAVIS, RUTH A | 13d |
| 18865316 | Membrane-forming composition, membrane-like composition, and use of same | WAX, ROBERT A | — |
| 18134993 | COMPOSITIONS INCLUDING ENDOPHYTES FOR IMPROVING PLANT NUTRITION, GROWTH,AND PERFORMANCE AND METHODS OF USING THE SAME | LIU, SUE XU | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18143052 | MANUFACTURING PROCESS FOR PRODUCING AMMONIA FROM ANAEROBIC DIGESTATE LIQUID | NORRIS, CLAIRE A | 45d overdue |
| 18120319 | COMPOSITIONS INCLUDING ENDOPHYTES FOR IMPROVING PLANT NUTRITION, GROWTH,AND PERFORMANCE AND METHODS OF USING THE SAME | DAVIS, RUTH A | 13d |
| 19008253 | DIGITAL HEALTH ROBOTIC SYSTEM FEATURING DIGITAL HEALTH ROBOT DEVICES AND RELATED METHODS | REYES, REGINALD R | 28d |
| 18134993 | COMPOSITIONS INCLUDING ENDOPHYTES FOR IMPROVING PLANT NUTRITION, GROWTH,AND PERFORMANCE AND METHODS OF USING THE SAME | LIU, SUE XU | — |
| Client (Assignee) | Pending OAs |
|---|---|
| University of Washington | 2 |
| Lyons Global | 1 |
| Flory Industries | 1 |
| Towa Pharmaceutical Co. Ltd. | 1 |
| NATURAL AMMONIA PRODUCTS, LLC | 1 |
| Art Unit | Apps |
|---|---|
| 3684 | 1 |
| 1779 | 1 |
| 1616 | 1 |
| 1699 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19008253 | DIGITAL HEALTH ROBOTIC SYSTEM FEATURING DIGITAL HEALTH ROBOT DEVICES AND RELATED METHODS | Lyons Global, LLC | REYES, REGINALD R | 3684 | §103 | Final Rejection | 28d | Pending | Jan 02, 2025 |
| 18985084 | TREE FRUIT OR NUT HARVESTER TO MINIMIZE MACHINE PASSES IN THE ORCHARD | Flory Industries | HARCOURT, BRAD | §102DP | Non-Final OA | — | Pending | Dec 18, 2024 | |
| 18865316 | Membrane-forming composition, membrane-like composition, and use of same | Towa Pharmaceutical Co. Ltd. | WAX, ROBERT A | §103§112 | Non-Final OA | — | Pending | Nov 12, 2024 | |
| 18143052 | MANUFACTURING PROCESS FOR PRODUCING AMMONIA FROM ANAEROBIC DIGESTATE LIQUID | Natural Ammonia Products, LLC | NORRIS, CLAIRE A | 1779 | §112Other | Final Rejection | 45d overdue | Pending | May 03, 2023 |
| 18134993 | COMPOSITIONS INCLUDING ENDOPHYTES FOR IMPROVING PLANT NUTRITION, GROWTH,AND PERFORMANCE AND METHODS OF USING THE SAME | UNIVERSITY OF WASHINGTON | LIU, SUE XU | 1616 | §102§103 | Non-Final OA | — | Pending | Apr 14, 2023 |
| 18120319 | COMPOSITIONS INCLUDING ENDOPHYTES FOR IMPROVING PLANT NUTRITION, GROWTH,AND PERFORMANCE AND METHODS OF USING THE SAME | UNIVERSITY OF WASHINGTON | DAVIS, RUTH A | 1699 | §101§102§103§112Other | Non-Final OA | 13d | Pending | Mar 10, 2023 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial